🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-524045-27-00
Terminated Phase I/II

Late immunity following single immunization with GA2 sporozoites (GACHA)

2025-524045-27-00 · tracked via the Priya Life Science EU tracker
Sponsor
Leids Universitair Medisch Centrum (LUMC)
Sponsor type
Hospital/Clinic/Other health care facility
Therapeutic area
Parasitic Diseases
Decision date
09/03/2026
Enrollment target
20
Sites
Netherlands

Condition studied

Falciparum malaria

Eligibility

Age group
18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-524045-27-00 on CTIS ↗ ← All trials in the EU